Palo Alto, CA, United States of America

Daniel M Klass

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Leland Stanford Junior University. Active years: 2021.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Daniel M Klass

Introduction

Daniel M Klass is an accomplished inventor based in Palo Alto, California. He has made significant contributions to the field of molecular biology, particularly in the identification and analysis of nucleic acids. His work has implications for cancer detection and diagnosis, showcasing the intersection of technology and healthcare.

Latest Patents

Daniel M Klass holds a patent titled "Identification and use of circulating nucleic acids." This patent discloses polynucleotide adaptors and methods for identifying and analyzing nucleic acids, including cell-free nucleic acids from patient samples. The methods described in the patent are designed to detect, diagnose, or determine the prognosis of cancers, highlighting the potential for improved patient outcomes through innovative technology. He has 1 patent to his name.

Career Highlights

Klass is affiliated with Leland Stanford Junior University, where he continues to engage in groundbreaking research. His work at the university allows him to collaborate with other leading scientists and contribute to advancements in medical technology.

Collaborations

Some of his notable coworkers include Arash Ash Alizadeh and Aaron M Newman. Their collaborative efforts enhance the research environment and foster innovation in their respective fields.

Conclusion

Daniel M Klass exemplifies the spirit of innovation in the realm of molecular biology. His contributions through patents and research at Leland Stanford Junior University are paving the way for advancements in cancer detection and treatment.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…